Pharmaceuticals
India to spend 100 billion rupees to make biopharma production hub
The funding will be directed towards the research and production of biologics and biosimilar medicines
US FDA launches programme to boost domestic drug manufacturing
It’s in line with President Donald Trump’s executive order in May to shift manufacturing of drugs to the US
How China rewrote the rules of drug innovation
In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory velocity becomes a binding constraint
CEO of Salonpas maker seeks to take the 450 billion yen drug firm private
The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ages
Pfizer forecasts 2026 profit below expectations on lower Covid product sales
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences
Malaysia’s retail pharmacy boom draws billion-ringgit bets as IPO pipeline builds
The catalyst – news that BIG Caring Group is weighing a blockbuster listing in Bursa Malaysia next year
Chemistry AI startup ChemLex raises US$45 million, sets up global HQ in Singapore
The funds will be used to hire more hardware and software engineers as well as chemists in the city-state
US, UK announce deal on pharmaceutical tariffs, drug pricing
[WASHINGTON] The Trump administration has reached an agreement with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to ...
What China will dominate next
The country’s high-speed innovation holds lessons for the world
